Author:
Paul I,Chacko A D,Stasik I,Busacca S,Crawford N,McCoy F,McTavish N,Wilson B,Barr M,O'Byrne K J,Longley D B,Fennell D A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference40 articles.
1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ . Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5–26.
2. Fennell DA . Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res 2005; 11: 2097–2105.
3. Klastersky J, Awada A . Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC). Crit Rev Oncol Hematol 2012; 81: 49–57.
4. Belani CP, Langer C . First-line chemotherapy for NSCLC: an overview of relevant trials. Lung Cancer 2002; 38 (Suppl 4): 13–19.
5. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92–98.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献